Diabetes mellitus, type 2

Diabetes mellitus, type 2 

Updated: 01/21/2021

© Jun Wang, MD, PhD

General features
  • Complex etiology
  • Much more common than type 1 diabetes
  • Not absolutely dependent on insulin
  • Onset most often in adults
  • Fungal infection due to impaired lymphocytic function
  • Commonly associated with chronic macrovascular, microvascular and neuropathic complications
Key risk factors
  • Genetics
Susceptible genotype
Family history of type 2 diabetes in a first degree relative
  • Possible risk factors
Obesity
Hypertension/dyslipidemia
Lower birth weight
Environmental pullutants
History of impaired glucose tolerance, gestational diabetes, etc
Insulin resistance and metabolic syndrome
Polycystic ovary disease
Others: immunization, diet, etc
Key pathogenesis
  • Combination of insulin resistance, relatively inadequate insulin secretion, and excessive or inappropriate glucagon secretion
  • Obesity associated elevated free fatty acid and glucose eventually result in beta cell failure
  • Impaired metabolism in carbohydrate
  • Subsequent multi-organ dysfunction due to hyperglycemia
Insulin resistance
  • Less-than-expected biological effect by a given amount of insulin
Failure to inhibit gluconeogenesis, resulting high fasting blood glucose levels
Failure of glucose uptake and glycogen synthesis following a meal, resulting high post-prandial blood glucose level
Failure to inhibit activation of "hormone-sensitive" lipase, leading to excess triglyceride breakdown in adipocytes and excess circulating free fatty acids (FFAs)
  • Associated with reduced insulin receptor quantity or receptor signaling pathway defects
  • May be caused by free fatty acid, adipokines, inflammation
  • Associated with various endocrine, metabolic, and genetic conditions
  • Present with obesity, glucose intolerance, diabetes, and the metabolic syndrome, as well as an extreme insulin-resistant state
Metabolic syndrome
  • Insulin resistance accompanying abnormal adipose metabolism
  • Risk factor for type 2 diabetes
  • Definition by National Cholesterol Education Program Adult Treatment Panel III, 3 of the below
Glucose ≥5.6 mmol/L (100 mg/dL) or drug treatment for elevated blood glucose
HDL: <1.0 mmol/L (40 mg/dL) (men); <1.3 mmol/L (50 mg/dL) (women) or drug treatment for low HDL-C
Tryglycerides: ≥1.7 mmol/L (150 mg/dL) or drug treatment for elevated triglycerides
Hypertension: ≥130/85 mmHg or drug treatment for hypertension
Obesity: Waist ≥102 cm (men) or ≥88 cm (women)
Beta cell failure
  • Occurs prior to diabetes
  • Reduced quantity due to increased apoptosis caused by various hormones or growth factors
  • Functional defects due to abnormal incretin effect, prolonged hyperglycemia and elevated levels of free fatty acid, amyloid or certain genetic factors affecting insulin secretion
Clinical presentations
  • Classic presentations: polyuria, polydipsia, polyphagia, weight loss
  • Presentations of complications: Hyperosmolar hyperosmotic syndrome, etc
  • Non specific presentations: fatigue, nausea, blurred vision, lower-extremity paresthesia
  • Fungal infection
Key Laboratory findings
  • Elevated fasting glucose
  • Impaired glucose tolerance
  • Glycated hemoglobin (HbA1c): Long term monitoring
  • Urinary albumin: in patient with diabetic nephropathy
  • Normal or elevated Insulin levels
  • Normal or elevated level of C-peptide
  • Tests for complications: osmolality, etc
  • NO autoantibodies
Pathological changes
  • Amyloid deposit in islet

Type 2 versus Type 1


Managements
  • Systemic approaches
  • Glycemic control and monitoring
  • Balanced nutrition, exercise, smoke cessation
  • Immunizations
  • Psychosocial support
  • Pharmacologic therapy: Biguanides, sulfonylureas, etc
  • Managements of complications



Back to contents

Comments

Post a Comment

Popular posts from this blog

Contents

Pathology notes Jun Wang, MD, PhD 1. General information Frequently discussed syndromes Terms of dermatology Terms of hematology 2. Primary immunodeficiency disorders 3. Hemodynamic abnormalities Shock Thrombosis and embolism Bleeding disorders 4.  Benign blood cell disorders Anemia Benign white cell disorders 5. Hematopoietic neoplasms Lymphoid neoplasms Myeloid neoplasms Histiocytic neoplasms: Langerhans cell histiocytosis 6. Cardiovascular system Pulmonary hypertension Cardiovascular system tumors 7. Respiratory tract tumors 8. Gastrointestinal tract Congenital disorders Infectious gastroenteritis Oral cavity Esophagus Stomach Intestinal tumors Salivary glands Exocrine pancreas and gallbladder 9. Urinary system Kidney masses Lower urinary tract 10. Male reproductive system 11. Female genital tract 12. Breast 13. Endocrine organs Pituitary gland Adrenal gland Thyroid gland Parathyroid gland Endocrine pancreas M
Read more

Anemia

Anemia Updated: 07/13/2024 © Jun Wang, MD, PhD   General features Decrease in red cell mass Hemoglobin: Levels of hemoglobin in a specific volume of whole blood Hematocrit: Fraction of whole blood composed of red blood cells Red cell count: Quantity of red cell in a specific volume of whole blood Three major groups based on RBC sizes Microcytic Normocytic Macrocytic Three major causes Blood loss: acute or chronic Increased red cell destruction: hemolysis Reduced production: marrow failure due to genetic abnormality or nutritional deficiency Etiology Genetic abnormality Hemoglobinopathies RBC cytoskeletal abomorlities Enzyme abnormalities Fanconi anemia Nutritional deficiencies: iron, VB12, folate, general malnutrition Physical etiologies: trauma, burns, frostbite, prosthetic valves, etc Chronic diseases: chronic infections, neoplasia, autoimmune disorders, kidney or liver diseases, etc Infectious diseases: hepatitis, sepsis , malaria, etc
Read more

Lymphoid neoplasms

Lymphocytic neoplasms Updated: 05/17/2020 © Jun Wang, MD, PhD Terminology Lymphoma : Proliferations forming discrete tissue masses Leukemia : Widespread involvement of the bone marrow and usually the peripheral blood Any "lymphoma" can present with or evolve to a leukemic picture, and any "leukemia" can occasionally present with a mass lesion Other hematology terms Important risk factors Immunodeficiency (primary or secondary) Autoimmune disorders Viruses (HIV, KSHV/HHV8, HTLV-1) H. pylori infection Radiation Chemotherapy Diagnostic approaches Complete history, especially those with possible epidemic characters, such as Burkitt lymphoma CBC, Bone marrow Morphology/immunohistochemistry Immunofluorescence flow cytometry Cytogenetic studies Molecular studies Commonly used markers All lymphomas: CD45 B-cell neoplasms: CD5, CD10, CD19, CD20, CD79a, CD23, bcl2, bcl6, cyclin D1, light chai
Read more